Last week, we covered new KFF research on Medicare Advantage (MA) television advertisements that aired during the Fall of 2022,...
Two new KFF research reports capture the prolific—and often problematic—nature of Medicare Advantage (MA) television advertisements during Medicare’s fall open...
A new survey from the Commonwealth Fund examines beneficiary experiences with marketing outreach from private Medicare Advantage (MA), Medigap, and...
On Tuesday, the Centers for Medicare & Medicaid Services (CMS) announced the first 10 Medicare Part D drugs that will...
Many of Medicare’s 65 million enrollees can struggle to pay for coverage and care. The program’s benefit design and lack...
This week, the Medicare Rights Center released Medicare Advantage 101, a new set of fact sheets and videos that delve into the...
The Inflation Reduction Act (IRA) made key changes to improve prescription drug affordability for people with Medicare. Important reforms that...
This week, the Centers for Medicare & Medicaid Services (CMS) released two new data tools as part of the Biden-Harris...
During most of the COVID-19 pandemic, states were allowed to keep people continuously enrolled in Medicaid in exchange for enhanced...
For many low-income Medicare beneficiaries, the Part D Low-Income Subsidy (LIS) program (also called “Extra Help”) can be a lifeline,...
2,400+ Champions stand with older Americans. Your gift keeps the helpline free, the policy work loud, and the next 30 years possible. Will you join them?
Become a Champion →
